Regulation of serotonin(1A), glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression

Biological Psychiatry

Volumn 43, Issue 8, 1998, Pages 547-573

  López, Juan F ^a   Chalmers, Derek T ^b   Little, Karley Y ^a   Watson, Stanley J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b ARENA PHARMACEUTICALS   (United States)

Author keywords

Corticosteroids; Hippocampus; Imipramine; Serotonin(1A) receptors; Stress

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOSTERONE; DESIPRAMINE; GLUCOCORTICOID RECEPTOR; IMIPRAMINE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; SEROTONIN 1A RECEPTOR; ZIMELDINE; SEROTONIN RECEPTOR;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DEPRESSION; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS; SUICIDE; SWIMMING; ANIMAL; BIOSYNTHESIS; BLOOD; DRUG EFFECT; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADRENALECTOMY; ANIMALS; ANTIDEPRESSIVE AGENTS; AUTORADIOGRAPHY; CORTICOSTERONE; DEPRESSION; HIPPOCAMPUS; HUMANS; IN SITU HYBRIDIZATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RECEPTORS, SEROTONIN; RNA, MESSENGER; STRESS, PSYCHOLOGICAL; SUICIDE; SWIMMING;

EID: 0032521829     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00484-8     Document Type: Article

References (86)

1. Albert PR, Zhou QY, Van Tol HHM, Bunzow JR, Civelli O. Cloning functional expression and mRNA tissue distribution of the rat 5-hydroxytryptamine 1A receptor gene. J Biol Chem. 265:1990;5825-5832.
2. 2 and b-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry. 47:1990;1038-1047.
3. Arango V, Underwood MD, Gubbi AV, Mann JJ. Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res. 688:1995;121-133.
4. Armario A, Restrepo C, Lopez-Calderon A. Effect of a chronic stress model of depression on basal and acute stress levels of LH and prolactin in adult male rats. Biol Psychiatry. 24:1988;447-450.
5. Baker GB, Greenshaw AJ. Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cell Mol Neurobiol. 9:1988;1-44.
6. Biegon A. Effects of steroid hormones on the serotonergic system. Ann NY Acad Sci. 600:1990;427-431.
7. Biegon A, Rainbow TC, McEwen BS. Corticosterone modulation of neurotransmitter receptors in rat hippocampus A quantitative autoradiographic study . Brain Res. 332:1985;309-314.
8. Blier P, de Montigny C. Current advances and trends in the treatment of depression. Trends Pharmacol Sci. 15:1994;220-226.
9. Blier P, De Montigny C, Chaput Y. Electrophysiological assessment of the effects of antidepressant treatments on the efficacy of 5-HT neurotransmission. Clin Neuropharmacol. 11:(suppl 2):1988;S1-S10.
10. Bowen DM, Najlerahim A, Procter AW, Francis PT, Murphy E. Circumscribed changes of the cerebral cortex in neuropsychiatric disorder of later life. Proc Natl Acad Sci USA. 86:1989;9504-9508.
11. Brady LS, Whitfield HJ Jr, Fox RJ, Gold PW, Herkenham M. Long term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. J Clin Invest. 87:1991;831-837.
12. Brown GW, Harris TO, Hepworth C. Life events and endogenous depression. A puzzle reexamined. Arch Gen Psychiatry. 51:1994;525-534.
13. Burnet PW, Eastwood SL, Lacey K, Harrison PJ. The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain. Brain Res. 676:1995;157-168.
14. Carroll BJ, Curtis GC, Mendels J. Neuroendocrine regulation in depression I. Limbic system-adrenocortical dysfunction . Arch Gen Psychiatry. 33:1976;1039-1044.
15. Chalmers DT, Watson SJ. Comparative anatomical distribution of 5-HT1A receptor mRNA and 5-HT1A binding in rat brain - A combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res. 561:1991;51-60.
16. Chalmers DT, Kwak SP, Mansour A, Akil H, Watson SJ. Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression. J Neurosci. 13:1992;914-923.
17. Chalmers DT, Lopez JF, Vazquez DM, Akil H, Watson SJ. Regulation of hippocampal 5-HT1A receptor gene expression by dexamethasone. Neuropsychopharmacology. 10:1994;215-222.
18. Chappell PB, Smith MA, Kilts CD, et al. Alterations in corticotropin-releasing factor-like immunoreactivity in discreate rat brain regions after acute and chronic stress. J Neurosci. 6:1986;2908-2914.
19. Clerc GE, Ruimy P, Verdeau-Palles J. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group. Int Clin Psychopharmacol. 9:1994;139-143.
20. Curzon G, Joseph MH, Knott PJ. Effect of immobilization and food deprivation on rat brain tryptophan hydroxylase. J Neurochem. 19:1972;1967-1974.
21. Danielson PE, Forss-Petter S, Brow MA, et al. p1B15 A cDNA clone of the rat mRNA encoding cyclophilin . DNA. 7:1988;261-267.
22. De Kloet ER, Sybesma H, Reul HMHM. Selective control by corticosterone of serotonin 1 receptor capacity in raphe-hippocampal system. Neuroendocrinology. 42:1986;513-521.
23. De Kloet ER, Rosenfel P, Van Eekelen JAM, Sutanto W, Levine S. Stress, glucocorticoids and development. Boer GJ, Feenstra MGP, Swaab DF, Van Haaren F. Progress in Brain Research. vol 73:1988;101-120 Elsevier, Amsterdam.
24. Dillon KA, Gross-Isseroff R, Israeli M, Biegon A. Autoradiographic analysis of serotonin 5-HT1A receptor binding in the human brain postmortem Effects of age and alcohol . Brain Res. 554:1991;56-64.
25. Fabre LF. Buspirone in the management of major depression A placebo-controlled comparison . J Clin Psychiatry. 51:1990;55-61.
26. Frank E, Anderson B, Reynolds CF, Ritenour A, Kupfer DJ. Life events and the research diagnostic criteria endogenous subtype. A confirmation of the distinction using the Bedford College methods. Arch Gen Psychiatry. 51:1994;519-524.
27. Gold PW, Loriaux DL, Roy A, et al. Response to corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. N Engl J Med. 314:1986;1329-1335.
28. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (second of two parts). N Engl J Med. 319:1988;413-420.
29. Greden JF, Gardner R, King D, Grunhaus L, Carroll BJ, Kronfol Z. Dexamethasone suppression test in antidepressant treatment of melancholia. Arch Gen Psychiatry. 40:1983;493-500.
30. Hall MD, Mestikawy SE, Emerit MB, Pichat L, Hamon M, Gozlan H. [3H] 8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain. J Neurochem. 44:1985;1685-1696.
31. Herman JP, Patel PD, Akil H, Watson SJ. Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol Endocrinol. 3:1989;1886-1894.
32. Herman JP, Shafer MK-H, Young EA, et al. Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J Neurosci. 9:1989;3072-3082.
33. Holsboer F, Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev. 17:1996;187-203.
34. Hoyer DH, Martin GR. Classification and nomenclature of 5-HT receptors A comment on current issues . Behav Brain Res. 73:1996;263-268.
35. Isaacson RL. The Limbic System. 1974;Plenum Press, New York.
36. Jacobsen FM. Possible augmentation of antidepressant response by buspirone. J Clin Psychiatry. 52:1991;217-220.
37. Joels M, Hesen W, De Kloet ER. Mineralocorticoid hormones suppress serotonin-induced hyperpolarization of rat hippocampal CA1 neurons. J Neurosci. 11:1991;2288-2294.
38. Kathol RG. Etiologic implications of corticosteroid changes in affective disorder. Psychiatr Med. 3:1985;135-155.
39. Kathol RG, Jaeckel RS, Lopez JF, Meller WH. Pathophysiology of HPA axis abnormalities in patients with major depression An update . Am J Psychiatry. 146:1989;311-317.
40. Katz RJ, Sibel M. Animal model of depression Tests of three structurally and pharmacologically novel antidepressant compounds . Pharmacol Biochem Behav. 16:1982;973-977.
41. Kuroda Y, Watanabe Y, Albeck DS, Hastings NB, McEwen BS. Effects of adrenalectomy and type I or type II glucocorticoid receptor activation on 5-HT1A and 5-HT2 receptor binding and 5-HT transporter mRNA expression in rat brain. Brain Res. 648:1994;157-161.
42. Little KY, Clark TC, Ranc J, Duncan GE. Altered b-adrenergic binding in frontal cortex of suicides. Biol Psychiatry. 34:1993;596-605.
43. Lopez JF, Young EA, Herman JP, Akil H, Watson SJ (1991): Regulatory Biology of the HPA Axis: An Integrative Approach, 1st ed, vol 30. Washington DC: American Psychiatric Press.
44. Lopez JF, Palkovits M, Arato M, Mansour A, Akil H, Watson SJ. Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinology. 56:1992;491-501.
45. Lopez JF, Chalmers DT, Vazquez DM, Watson SJ, Akil H. Serotonin transporter mRNA in rat brain is regulated by classical antidepressants. Biol Psychiatry. 35:1994;287-290.
46. Lopez JF, Vazquez DM, Akil H, Watson SJ. Effect of imipramine administration and swim stress on the hypothalamic pituitary adrenal axis. Endocrine. 2:1994;723-728.
47. Lucki I. Behavioral studies of serotonin receptor agonists as antidepressant drugs. J Clin Psychiatry. 52:1991;24-31.
48. Mann JJ, Arango V, Marzuk PM, Theccanat S, Reis DJ. Evidence for the 5-HT hypothesis of suicide A review of post-mortem studies . Br J Psychiatry. 155:1989;7-14.
49. McEwen BS. Glucocorticoid-biogenic amine interactions in relation to mood and behavior. Biochem Pharmacol. 36:1987;1755-1763.
50. McEwen BS. Stress and hippocampus. An update on current knowledge. Presse Med. 20:1991;1801-1806.
51. McKittrick CR, Blanchard DC, Blanchard RJ, McEwen BS, Sakai RR. Serotonin receptor binding in a colony model of chronic social stress. Biol Psychiatry. 37:1995;383-396.
52. Meijer OC, De Kloet ER. Corticosterone suppresses the expression of 5-HT1A receptor mRNA in rat dentate gyrus. Eur J Pharmacol. 266:1994;255-261.
53. Meltzer HY. Role of serotonin in depression. Psychopharmacology. 96:1988;134.
54. Meltzer H. Serotonergic dysfunction in depression. Br J Psychiatry. 155:1989;25-31.
55. Mendelson SD, McEwen BS (1990): Adrenalectomy increases the density of 5-HT1A receptors in rat hippocampus. 12:353.
56. Murphy BEP. Steroids and depression. J Steroid Biochem. 38:1991;537-559.
57. Murphy BEP, Dhar V, Ghadirian AM, Chouinard G, Keller R. Response to steroid suppression in major depression resistant to antidepressant therapy. J Clin Psychopharmacol. 11:1991;121-126.
58. Nemeroff CB, Widerlov E, Bisette G, et al. Elevated concentrations of CSF corticotropin-releasing-factor-like immunoreactivity in depressed patients. Science. 226:1984;1342-1344.
59. Palacios JM, Pazos A, Hoyer D. Characterization and Mapping of 5-Ht1A Sites in the Brain of Animals and Man. 1987;Ellis Horwood, Chichester, UK.
60. Patel PD, Sherman TG, Goldman DJ, Watson SJ. Molecular cloning of a mineralocorticoid (Type I) receptor complementary DNA from rat hippocampus. Mol Endocrinol. 3:1989;1877-1885.
61. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. 1986;Academic Press, Orlando.
62. Pazos A, Probst A, Palacios JM. Serotonin receptors in the human brain - IV. Autoradiographic mapping of serotonin-2 receptors. Neuroscience. 21:1987;123-139.
63. Peiffer A, Veilleux S, Barden N. Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain. Psychoneuroendocrinology. 16:1991;505-515.
64. Peroutka SJ, Snyder SH (1979): Multiple serotonin receptors: Differential binding of [3H]-5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]-spiperidol. 16:687-699.
65. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry. 149:1992;999-1010.
66. Pranzatelli MR. Dissociation of the plasticity of 5-HT1A sites and 5-HT transporter sites. Neurochem Res. 19:1994;311-315.
67. Rickels K. Buspirone in clinical practice. J Clin Psychiatry. 51:1990;51-54.
68. Robinson DS, Rickels K, Feighner J, et al. Clinical effects of the 5-HT1A partial agonists in depression A composite analysis of buspirone in the treatment of depression . J Clin Psychopharmacol. 10:(suppl):1990;67S-76S.
69. Roose SP, Glassman AH, Attia E, Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry. 151:1994;1735-1739.
70. Sachar EJ, Hellman L, Roffwary HP, Halpern FS, Fukush DK, Gallagher TF. Disrupted 24-hour patterns of cortisol secretion in psychotic depressives. Arch Gen Psychiatry. 28:1973;19-24.
71. Sapolsky RM, Krey LC, McEwen BS. Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. Proc Natl Acad Sci USA. 81:1984;6174-6177.
72. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging The glucocorticoid cascade hypothesis . Endocr Rev. 7:1986;284-301.
73. Seckl JR, Dickson KL, Fink G. Central 5,7-dihydroxytryptamine lesions decrease hippocampal glucorticoid and mineralocorticoid receptor messenger ribonucleic acid expression. J Neuroendocrinol. 2:1990;911-916.
74. Seckl JR, Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo. Neuroendocrinology. 55:1992;621-626.
75. Terrazzino S, Perego C, De Simoni MG. Effect of development of habituation to restraint stress on hypothalamic noradrenaline release and adrenocorticotropin secretion. J Neurochem. 65:1995;263-267.
76. Van Loon GR, Shum A, Sole MJ. Decreased brain serotonin turnover after short term (two hour) adrenalectomy in rats A comparison of four turnover methods . Endocrinology. 108:1981;1392-1402.
77. Vazquez DM, Morano MI, Lopez JF, Watson SJ, Akil H. Short-term adrenalectomy increases glucocorticoid and mineralocorticoid receptor mRNA in selective areas of the developing hippocampus. Mol Cell Neurosci. 4:1993;455-471.
78. Vazquez DM, Van Oers H, Levine S, Akil H. Regulation of glucocorticoid and mineralocorticoid receptor mRNAs in the hippocampus of the maternally deprived infant rat. Brain Res. 731:1996;79-90.
79. Verge D, Davel G, Marcinkiewicz M, et al. Quantitative autoradiography of multiple 5-HT1 receptor subtypes in the brain of control or 5,7 dihydroxytryptamine treated rats. J Neurosci. 6:1986;3474-3482.
80. Watanabe Y, Sakai RR, McEwen BS, Mendelson S. Stress and antidepressant effects on hippocampal and cortical 5-HT1A and 5-HT2 receptors and transport sites for serotonin. Brain Res. 615:1993;87-94.
81. Welner SA, Montigny CD, Desroches J, Desjardins P, Suranyi-Cadotte BE. Autoradiographic quantification of serotonin 1A receptors in rat brain following antidepressant drug treatment. Synapse. 4:1989;347-352.
82. Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L. Antiglucocorticoid strategies in hypercortisolemic states. Psychopharmacol Bull. 28:1992;247-251.
83. Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L, Weingartner H. Ketoconazole administration in hypercortisolemic depression. Am J Psychiatry. 150:1993;810-812.
84. Young EA. Induction of the intermediate lobe pro-opiomelanocortin system with chronic swim stress and beta-adrenergic modulation of this induction. Neuroendocrinology. 52:1990;405-414.
85. Young EA, Haskett RF, Murphy-Weinberg V, Watson SJ, Akil H. Loss of glucocorticoid fast feedback in depression. Arch Gen Psychiatry. 48:1991;693-699.
86. Young EA, Akil H, Haskett RF, Watson SJ. Evidence against changes in corticotroph CRF receptors in depressed patients. Biol Psychiatry. 37:1995;355-363.